Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Bacopa monnieri extract (bacosides)

Bacopa Monnieri Extract (Synapsa / Bacopin) · also known as Bacopa monnieri, Water hyssop, Bacopa, Bacosides

Bacopa is a traditional herb used to boost cognition. A meta-analysis showed that taking it daily for about 12 weeks can modestly improve attention and information processing speed. Its effects on BDNF and on the cholinergic and monoamine systems come mostly from animal studies, and results in humans are mixed.

Typical dose: Standardized extract containing 45–55% bacosides, 300–450 mg/day, taken with breakfast or lunch
Absorption and forms: Bacosides are absorbed slowly, and taking them on an empty stomach may cause stomach upset. There is not enough evidence that they must be taken with a meal containing fat. Human studies typically run 4–12 weeks, but that time frame does not correspond to any proven process of synaptic remodeling.

Clinical uses and human evidence

Anxiety and stress

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Lopresti 2025 · Clin Drug Investig · RCT · n=101 — The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
  2. Calabrese 2008 · J Altern Complement Med · RCT · n=54 — Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial

Memory

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Tiemtad 2026 · Phytomedicine · Meta-analysis · n=2107 — Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
  2. Lopresti 2025 · Clin Drug Investig · RCT · n=101 — The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

Attention and focus

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Tiemtad 2026 · Phytomedicine · Meta-analysis · n=2107 — Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
  2. Lopresti 2025 · Clin Drug Investig · RCT · n=101 — The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

Age-related cognitive decline

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Delfan 2024 · Explore (NY) · RCT · n=62 — Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial

Mechanisms of action

Neurotrophic factor synthesis and TrkB/A receptor activation

★★★☆☆Mechanism evidence: grade APrimary target

One randomized trial in 80 people found higher serum BDNF than in the placebo group after 300 mg/day for 12 weeks. An open-label study in older adults, however, found no change in serum BDNF after 12 weeks. Changes in hippocampal TrkB receptors and dendritic spines have been seen mainly in animals.

References (2)
  1. Eraiah 2024 · RCT in 80 people: serum BDNF was higher than placebo after 300 mg/day for 12 weeks
  2. Keegan 2023 · Open-label study in older adults: no significant change in serum mature or precursor BDNF after 12 weeks

Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)

★★★☆☆Mechanism evidence: grade APrimary target

A randomized trial in 60 people observed lower plasma acetylcholinesterase activity at some time points. However, peripheral enzyme activity does not show how much the enzyme is inhibited in the brain. Changes in choline acetyltransferase in the cerebral cortex were not measured directly, and the extract used was standardized differently from this product.

References (1)
  1. Peth-Nui 2012 · RCT in 60 people: plasma acetylcholinesterase activity fell at some time points; the tested extract was standardized differently from this product

Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)

★★★☆☆Mechanism evidence: grade CSecondary target

In young rats, expression of tryptophan hydroxylase-2 and the serotonin transporter in the hippocampus changed. That does not prove that serotonin release increases in the adult brain. A human randomized trial found no significant change in monoamine oxidase activity, and there is no human evidence yet for an anti-anxiety effect.

References (2)
  1. Charles 2011 · Young rat study: mRNA expression of hippocampal TPH2 and the serotonin transporter changed
  2. Peth-Nui 2012 · Human randomized trial: no significant change in monoamine oxidase activity was found

Safety and drug interactions

Taking it on an empty stomach occasionally causes nausea, or diarrhea from faster bowel movements. It can cause a very slight slowing of heart rate, so people with bradycardia (slow heart rate) should use it with caution.

Additive sedation

Some people become drowsy after taking it. Each of these has some sedative or sleep-promoting effect. Taken together, they may cause daytime drowsiness and slower reactions. Do not drive or work at heights after taking them.

Open in the interactive app ›